Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Transform your health journey Doctor-approved medications, customized to your needs
The slower initiation is not optional for tolerability
Begin treatment Your provider will prescribe a weight loss medication like Zepbound if its right for you
A Complete Dosage Conversion Guide Tirzepatide has become one of the most widely used medications for weight management and blood-glucose control
Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist approved by the FDA for type 2 diabetes and chronic weight management
A Paradigm Shift: Metabolic Reprogramming as a New Anti-Cancer Strategy This study marks a significant innovation in the field of oncology by demonstrating that tirzepatide (TZP), a dual GIP/GLP-1 receptor agonist approved for type 2 diabetes, can be repurposed to suppress colorectal cancer (CRC) by reprogramming tumor metabolism
US$ 26.68
US$ 26.64
US$ 28.72
